Talphera TLPH
NASDAQ TLPH
$1.19 +0.00 (+0.00%)
At close: Aug 20, 2026 · 11:49 AM UTC

Talphera (TLPH) Gross Profit (2016 - 2023)

Talphera (TLPH) posted quarterly Gross Profit of $117000.0 for Q3 2023, up 134.62% year-over-year from $49868.9 in Q3 2022, and down 53.75% quarter-over-quarter from $253000.0 in Q2 2023.

Talphera (TLPH) Gross Profit (2016 - 2023) Analysis & Trends

Talphera's Gross Profit history runs 8 years deep, the most recent figure standing at $117000.0 for Q3 2023.

  • In Q3 2023, Gross Profit rose 134.62% year-over-year to $117000.0; the TTM figure through Mar 2024 stood at $160000.0 (up 106.7% YoY), while the FY2022 annual figure was -$2.6 million, down 177.11% from the prior year.
  • Gross Profit for Q3 2023 stood at $117000.0, down from $253000.0 in the prior quarter.
  • The five-year high for Gross Profit was $1.6 million in Q2 2020, with the low at -$1.5 million in Q3 2019.
  • The 5-year median for Gross Profit is -$538000.0 (2022), against an average of -$432578.9.
  • The sharpest annual moves came in 2019 and 2021: Gross Profit slumped 1359.42% in 2019, then surged 361.08% in 2021.
  • Talphera's Gross Profit stood at -$1.1 million in 2019, then surged by 50.83% to -$562000.0 in 2020, then sank by 119.22% to -$1.2 million in 2021, then retreated by 5.6% to -$1.3 million in 2022, then jumped by 108.99% to $117000.0 in 2023.
  • Business Quant data shows TLPH's Gross Profit at $117000.0 in Q3 2023, $253000.0 in Q2 2023, and -$210000.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.07 Bn 43.10 Bn -
2 Teva Pharmaceutical Industries 43.41 Bn 39.75 Bn 2.15 Bn
3 Zoetis 31.83 Bn 30.15 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.77 Bn 22.97 Bn 5.10 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn
7 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn
8 Elanco Animal Health 11.93 Bn 11.40 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn -
10 Talphera 89.88 Mn 89.88 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 117,000.00
Sep 30, 2023 117,000.00
Jun 30, 2023 253,000.00
Jun 30, 2023 253,000.00
Mar 31, 2023 -210,000.00
Mar 31, 2023 -210,000.00
Dec 31, 2022 -1.30 Mn
Dec 31, 2022 -1.30 Mn
Sep 30, 2022 -338,000.00
Sep 30, 2022 -338,000.00
Jun 30, 2022 -538,000.00
Jun 30, 2022 -538,000.00
Mar 31, 2022 28,000.00
Mar 31, 2022 28,000.00
Dec 31, 2021 -1.23 Mn
Dec 31, 2021 -1.23 Mn
Sep 30, 2021 1.26 Mn
Sep 30, 2021 1.26 Mn
Jun 30, 2021 -597,000.00
Jun 30, 2021 -597,000.00